Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

CADA blocks HIV entry by disrupting translocation of CD4 across ER membrane

Dec. 31, 2010

Preclinical and clinical data presented on BEZ-235

Dec. 31, 2010

Efficacy and safety data from ECHO and THRIVE trials of rilpivirine reported

Dec. 31, 2010

DermaPrep-delivered LC-002 shows promise in phase I/II trials in HIV

Dec. 31, 2010

[18F]-Marimastat-aryltrifluoroborate described as useful for PET imaging of breast cancer

Dec. 30, 2010

Scientists unveil mechanism leading to resistance of HIV to maraviroc

Dec. 30, 2010

MK-0752 shows promise in patients with breast cancer

Dec. 30, 2010

PF-3450074 inhibits HIV infection by destabilizing viral capsid

Dec. 30, 2010

Synthesis and effects of EC-23 on human stem cells described

Dec. 30, 2010

Telapristone shows promise in preclinical models of breast cancer

Dec. 29, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...